Cholesterol-lowering therapy may retard the progression of diabetic nephropathy

Diabetologia. 1996 Mar;39(3):367-8. doi: 10.1007/BF00418356.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Anticholesteremic Agents / therapeutic use*
  • Controlled Clinical Trials as Topic
  • Diabetes Mellitus, Type 1 / physiopathology
  • Diabetes Mellitus, Type 2 / physiopathology*
  • Diabetic Angiopathies / drug therapy*
  • Diabetic Nephropathies / physiopathology
  • Diabetic Nephropathies / prevention & control*
  • Follow-Up Studies
  • Glomerular Filtration Rate
  • Humans
  • Lovastatin / therapeutic use*
  • Proteinuria
  • Research Design

Substances

  • Anticholesteremic Agents
  • Lovastatin